[PDF] from uu.nlSLW Koolen, JJ Moes… - … -to-oral switch in …, 2011 - igitur-archive.library.uu.nl Chapter 2.3 62 Abstract Docetaxel is registered for 1-hour infusions in 3-weekly schedules. Oral administration of docetaxel, however, is feasible when given in combination with ritonavir, which is an inhibitor of the drug metabolizing enzyme CYP3A4. The aim of this study was to ... Related articles - View as HTML
[PDF] from pharmacie-globale.infoKR Bobe, CR Subrahmanya… - International …, 2011 - pharmacie-globale.info 1Department of Pharmaceutics, Al-Ameen College of Pharmacy, Bangalore, Karnataka, India. 2Indira Institute of Pharmacy, Sadavali (Devrukh), Ratnagiri, Maharashtra, India. 3Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, ... Cited by 1 - Related articles - View as HTML - All 2 versions
V Puri, A Dantuluri… - 1st Electron. Conf. Pharm. Sci., 2011 - sciforum.net Abstract: Amorphous solid dispersions (ASDs) offer a means to enhance oral bioavailability of poorly water soluble drugs. However, poor dissolution performance is one of the major challenges encountered in design of ASD based drug products. This study attempts to understand ... Cached
MJ Oh, EY Lee, WH Cho… - 약제학회지, 2011 - papersearch.net This study aimed to confirm the effect of molecular weight (MW) in solid dispersion of carvedilol with polyvinylpyrrolidone (PVP) of various MW. Solid dispersion of carvedilol with PVP was prepared by spray-drying method. Scanning electron microscopy (SEM) was used to analyze the ... Cached
[PDF] from uu.nlJJ Moes, SLW Koolen… - … -to-oral switch in …, 2011 - igitur-archive.library.uu.nl Chapter 3.2 118 Abstract A new oral solid dispersion formulation of paclitaxel (ModraPac001 10 mg capsules) administered in combination with the pharmacokinetic (PK) booster, ritonavir, has been developed and investigated in patients with advanced cancer. ... Related articles - View as HTML
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
